2.99BUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04530Y1064
CUSIP
04530Y106
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
June
IPO date
-
Updated At
-
PE Ratio
11.89
PEG Ratio
-
Book Value
191.59
Dividend Share
3.59
Dividend Yield
3.11%
Earnings Share
0.56
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
45,525,000,192
Gross Profit TTM
20,558,000,128
EBITDA
10,791,999,488
Profit Margin
9.84%
Return On Assets TTM
4.21%
Return On Equity TTM
5.25%
Revenue Per Share TTM
102.511
Qtly Revenue Growth YOY
3.90%
Diluted Eps TTM
0.56
Qtly Earnings Growth YOY
3.20%
Trailing PE
11.89
Forward PE
0
Price Sales TTM
0.0657
Price Book MRQ
0.6202
Enterprise Value Revenue
1
Enterprise Value EBITDA
10
157.17
1.24%25.41
1.19%143.16
0.00%51.98
0.00%28.27
0.00%36.50
-42.26%124.45
-3.78%14.77
-0.87%16.97
-0.50%10.40
-0.43%